{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T22:15:25Z","timestamp":1785795325851,"version":"3.56.0"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,6,5]]},"DOI":"10.7759\/cureus.61702","type":"journal-article","created":{"date-parts":[[2024,6,5]],"date-time":"2024-06-05T07:01:17Z","timestamp":1717570877000},"source":"Crossref","is-referenced-by-count":1,"title":["von Hippel-Lindau Syndrome and Secondary Hypertension: A Case Report"],"prefix":"10.7759","author":[{"given":"Sharan","family":"Bose","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kandasamy Venkataraju","family":"Rajalakshmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ananthakumar","family":"Perumal Kumaresan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jibin","family":"Simon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1093\/qjmed\/77.2.1151","article-title":"Clinical features and natural history of von Hippel-Lindau disease","volume":"77","author":"Maher ER","year":"1990","unstructured":"Maher ER, Yates JR, Harries R, Benjamin C, Harris R, Moore AT, Ferguson-Smith MA. Clinical features and natural history of von Hippel-Lindau disease. Q J Med. 1990, 77:1151-63. 10.1093\/qjmed\/77.2.1151","journal-title":"Q J Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)13643-4","article-title":"von Hippel-Lindau disease","volume":"361","author":"Lonser RR","year":"2003","unstructured":"Lonser RR, Glenn GM, Walther M, Chew EY, Libutti SK, Linehan WM, Oldfield EH. von Hippel-Lindau disease. Lancet. 2003, 361:2059-67. 10.1016\/S0140-6736(03)13643-4","journal-title":"Lancet"},{"key":"ref3","article-title":"Von Hippel-Lindau syndrome","author":"Van Leeuwaarde RS","year":"2024","unstructured":"Van Leeuwaarde RS, Ahmad S, Van Nesselrooij B. Von Hippel-Lindau syndrome. GeneReviews\u00ae. Adam MP, Feldman J, Mirzaa GM, et al. (ed): University of Washington, Seattle, Seattle, WA; 2024."},{"key":"ref4","unstructured":"The VHL Alliance. (2024). Accessed. February 18, 2024: http:\/\/www.vhl.org\/."},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1038\/nrc3183","article-title":"HIF1\u03b1 and HIF2\u03b1: sibling rivalry in hypoxic tumour growth and progression","volume":"12","author":"Keith B","year":"2011","unstructured":"Keith B, Johnson RS, Simon MC. HIF1\u03b1 and HIF2\u03b1: sibling rivalry in hypoxic tumour growth and progression. Nat Rev Cancer. 2011, 12:9-22. 10.1038\/nrc3183","journal-title":"Nat Rev Cancer"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1098-1004(1996)8:4<348::AID-HUMU8>3.0.CO;2-3","article-title":"Germline mutations in the Von Hippel-Lindau disease (VHL) gene in families from North America, Europe, and Japan","volume":"8","author":"Zbar B","year":"1996","unstructured":"Zbar B, Kishida T, Chen F, et al.. Germline mutations in the Von Hippel-Lindau disease (VHL) gene in families from North America, Europe, and Japan. Hum Mutat. 1996, 8:348-57. 10.1002\/(SICI)1098-1004(1996)8:4&lt;348::AID-HUMU8&gt;3.0.CO;2-3","journal-title":"Hum Mutat"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2015.65.6140","article-title":"Von Hippel-Lindau disease: genetics and role of genetic counseling in a multiple neoplasia syndrome","volume":"34","author":"Nielsen SM","year":"2016","unstructured":"Nielsen SM, Rhodes L, Blanco I, et al.. Von Hippel-Lindau disease: genetics and role of genetic counseling in a multiple neoplasia syndrome. J Clin Oncol. 2016, 34:2172-81. 10.1200\/JCO.2015.65.6140","journal-title":"J Clin Oncol"},{"key":"ref8","unstructured":"Research C for DEA. (2021). Accessed. February 16, 2024: https:\/\/www.fda.gov\/drugs\/resources-information-approved-drugs\/fda-approves-belzutifan-cancers-associated-von-hippel-...."},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2103425","article-title":"Belzutifan for renal cell carcinoma in von Hippel-Lindau disease","volume":"385","author":"Jonasch E","year":"2021","unstructured":"Jonasch E, Donskov F, Iliopoulos O, et al.. Belzutifan for renal cell carcinoma in von Hippel-Lindau disease. N Engl J Med. 2021, 385:2036-46. 10.1056\/NEJMoa2103425","journal-title":"N Engl J Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2015.63.0996","article-title":"American Society of Clinical Oncology Policy Statement Update: genetic and genomic testing for cancer susceptibility","volume":"33","author":"Robson ME","year":"2015","unstructured":"Robson ME, Bradbury AR, Arun B, et al.. American Society of Clinical Oncology Policy Statement Update: genetic and genomic testing for cancer susceptibility. J Clin Oncol. 2015, 33:3660-7. 10.1200\/JCO.2015.63.0996","journal-title":"J Clin Oncol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/247743-von-hippel-lindau-syndrome-and-secondary-hypertension-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,5]],"date-time":"2024-06-05T07:01:21Z","timestamp":1717570881000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/247743-von-hippel-lindau-syndrome-and-secondary-hypertension-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,5]]},"references-count":10,"URL":"https:\/\/doi.org\/10.7759\/cureus.61702","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6,5]]}}}